
XERS vs ACAD
$XERS vs $ACAD head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
XERS vs ACAD: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Their trends point opposite ways: XERS is above both its 50- and 200-day averages while ACAD is below both.
- ·Only XERS beat the market over the past year, by 124.8%, while ACAD trailed the S&P 500 at +8.8% by 32.6%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
XERS vs ACAD: the quick read
- ·XERS is the larger company by market cap ($3.10B vs $3.08B).
- ·XERS has been more active on our scanner (172 vs 114 alerts in 30 days).
- ·ACAD has the smaller float (170.1M vs 175.2M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 172 and 114 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: XERS is near the top of its 52-week range while ACAD is near the bottom of its own.
Objective differences only. Not investment advice.
Watching XERS or ACAD? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing XERS and ACAD on TheDesperateTrader.
- Is XERS or ACAD the better stock?
- "Better" depends on your goal, and these two are not alike. XERS is the larger company by market cap ($3.10B vs $3.08B). XERS has been more active on our scanner (172 vs 114 alerts in 30 days). ACAD has the smaller float (170.1M vs 175.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between XERS and ACAD?
- The differences that matter: they are similar in size ($3.10B vs $3.08B); they trade at very different share prices ($16.45 vs $17.64); XERS sits at 93% of its 52-week range against 12% for ACAD; our scanner flagged XERS 172 times in the last 30 days against 114 for ACAD. Everything above is measured from the latest completed session and SEC filings.
- Which of XERS and ACAD is more active right now?
- Right now XERS is at about 0.9x its normal volume and ACAD is at about 0.8x, so XERS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is XERS or ACAD in the stronger trend?
- XERS is above its 50-day average of $11.10 and above its 200-day average of $8.02; ACAD is below its 50-day average of $21.01 and below its 200-day average of $23.20. XERS leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading XERS or ACAD? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore XERS and ACAD comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.